Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Janssen Oncology Strategy: Take A Holistic Approach To R&D

Related Content

Kyprolis Wins Full Monotherapy OK, Broader Combo Use

Jan 22 2016

CASTOR Propels J&J's Anti-CD38 Darzalex To Prime Position In Myeloma

Jun 06 2016

Tesaro Adds Runway By Out-licensing Niraparib In Prostate Cancer

Apr 08 2016

Imbruvica Leads Sea Change In CLL Landscape

Mar 14 2016

Janssen/Genmab Win 1st Anti-CD38 In Multiple Myeloma

Nov 17 2015

BMS/AbbVie Empliciti Leaps Ahead, Wins Fast FDA Nod

Dec 01 2015

Related Companies

Johnson & Johnson

Takeda Pharmaceutical Co. Ltd.

Johnson & Johnson

Genmab A/S

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Amgen, Inc.

AbbVie Inc.

Astellas Pharma, Inc.

Tesaro, Inc.

Aduro Biotech, Inc.

CSL Limited

Geron Corporation

MacroGenics, Inc.

Additional Topics

Companies Cancer

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window